1. Home
  2. MTNB vs YCBD Comparison

MTNB vs YCBD Comparison

Compare MTNB & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTNB
  • YCBD
  • Stock Information
  • Founded
  • MTNB 2013
  • YCBD 2015
  • Country
  • MTNB United States
  • YCBD United States
  • Employees
  • MTNB N/A
  • YCBD N/A
  • Industry
  • MTNB Biotechnology: Pharmaceutical Preparations
  • YCBD Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTNB Health Care
  • YCBD Health Care
  • Exchange
  • MTNB Nasdaq
  • YCBD Nasdaq
  • Market Cap
  • MTNB 7.9M
  • YCBD 7.8M
  • IPO Year
  • MTNB N/A
  • YCBD N/A
  • Fundamental
  • Price
  • MTNB $2.36
  • YCBD $0.76
  • Analyst Decision
  • MTNB Hold
  • YCBD Strong Buy
  • Analyst Count
  • MTNB 1
  • YCBD 1
  • Target Price
  • MTNB N/A
  • YCBD $3.00
  • AVG Volume (30 Days)
  • MTNB 1.2M
  • YCBD 104.3K
  • Earning Date
  • MTNB 08-26-2025
  • YCBD 08-14-2025
  • Dividend Yield
  • MTNB N/A
  • YCBD N/A
  • EPS Growth
  • MTNB N/A
  • YCBD N/A
  • EPS
  • MTNB N/A
  • YCBD N/A
  • Revenue
  • MTNB N/A
  • YCBD $19,026,064.00
  • Revenue This Year
  • MTNB N/A
  • YCBD $7.67
  • Revenue Next Year
  • MTNB N/A
  • YCBD $10.00
  • P/E Ratio
  • MTNB N/A
  • YCBD N/A
  • Revenue Growth
  • MTNB N/A
  • YCBD N/A
  • 52 Week Low
  • MTNB $0.47
  • YCBD $0.76
  • 52 Week High
  • MTNB $8.00
  • YCBD $6.54
  • Technical
  • Relative Strength Index (RSI)
  • MTNB 86.61
  • YCBD 35.38
  • Support Level
  • MTNB $1.33
  • YCBD $0.81
  • Resistance Level
  • MTNB $1.85
  • YCBD $0.96
  • Average True Range (ATR)
  • MTNB 0.28
  • YCBD 0.08
  • MACD
  • MTNB 0.13
  • YCBD -0.01
  • Stochastic Oscillator
  • MTNB 67.88
  • YCBD 0.00

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Share on Social Networks: